We advised the sole bookrunning manager on the IPO

Davis Polk advised the sole bookrunning manager in connection with the initial public offering of 10 million Class A ordinary shares of TCGX Acquisition Corp. II for aggregate proceeds of $100 million. The shares are listed on the Nasdaq Capital Market under the symbol “TCXB”.

TCGX Acquisition Corp. II was formed for the purpose of effecting a business combination with one or more businesses. The SPAC intends to focus its search on healthcare and healthcare-related businesses, with a primary emphasis on medical technology and broader life sciences.

The Davis Polk capital markets team included partner Derek Dostal and associates Robert Van de Mark and Dylan Roache. Counsel Marcie A. Goldstein and Katia Brener provided FINRA advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post